Document ID: chunk:federal_register_of_legislation:F2022C00903:front:0:p4
Version: federal_register_of_legislation:F2022C00903
Segment Type: other
Provision Reference: 
Character Range: 8831–11850

months before the clinical onset of pulmonary thromboembolism;
(21)      having an injury or illness as specified within the six months before the clinical onset of pulmonary thromboembolism;
            Note: injury or illness as specified is defined in the Schedule 1 - Dictionary.
(22)      having restricted mobility for a continuous period of at least four hours within the eight weeks before the clinical onset of pulmonary thromboembolism;
Note: Examples of situations in which restricted mobility can occur include travel by road, rail or air and physical restraint.
(23)      having a neurological disease that causes loss or impairment of motor function of a limb within the three months before the clinical onset of pulmonary thromboembolism;
Note: Examples of neurological diseases that cause loss or impairment of motor function of a limb include cerebrovascular accident, multiple sclerosis and motor neurone disease.
(24)      having a clinically significant disorder of mental health as specified at the time of the clinical onset of pulmonary thromboembolism;
Note: clinically significant disorder of mental health as specified is defined in the Schedule 1 - Dictionary.
(25)      taking a drug from the specified list of drugs within the three months before the clinical onset of pulmonary thromboembolism;
            Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(26)      taking combined estrogen-progestogen contraception or taking menopausal hormone therapy as an oral estrogen, or a non-oral estrogen combined with a progestogen, for a continuous period of at least four weeks, within the three months before the clinical onset of pulmonary thromboembolism;
            Note: menopausal hormone therapy is defined in the Schedule 1 - Dictionary.
(27)      having smoked tobacco products:
(a)          in an amount of at least one pack-year before the clinical onset of pulmonary thromboembolism; or
(b)          in an amount of at least 10 cigarettes per day, or the equivalent thereof in other tobacco products, for a period of at least three months before the clinical onset of pulmonary thromboembolism; and
if smoking has ceased before the clinical onset of pulmonary thromboembolism, then that onset occurred within six months of cessation;
Note: cigarettes per day, or the equivalent thereof in other tobacco products and one pack-year are defined in the Schedule 1 - Dictionary.
(28)      being at an altitude of at least 3,000 metres for a continuous period of at least five days within the three months before the clinical onset of pulmonary thromboembolism;
(29)      inability to obtain appropriate clinical management for pulmonary thromboembolism.
     10           Relationship to service
(1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
(2)          The factor set out in subsection 9(29) applies only to material contribution to, or aggravation of, pulmonary